✦ LIBER ✦

Pharmacokinetic and pharmacodynamic studies with 4′-epi-doxorubicin in nasopharyngeal carcinoma patients

✍ Scribed by Oliver Yoa-Pu Hu; Shiu-Pei Chang; Jer-Min Jame; Kuang-Yao Chen

Publisher: Springer
Year: 1989
Tongue: English
Weight: 556 KB
Volume: 24
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00304769

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic stud

Pharmacokinetic and pharmacodynamic studies with mitoxantrone in the treatment of patients with nasopharyngeal carcinoma

✍ Oliver Yoa-Pu Hu; Shiu-Pei Chang; Chi-Kong Law; Jer-Min Jian; Kuang-Yao Chen 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Comparison of the intracellular pharmaco

Comparison of the intracellular pharmacokinetics of doxorubicin and 4′-epi-doxorubicin in patients with acute leukemia

✍ Ulf Tidefelt; Britt Sundman-Engberg; Christer Paul 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 537 KB

Cellular and plasma pharmacokinetics of

Cellular and plasma pharmacokinetics of weekly 20-mg 4′-epi-adriamycin bolus injection in patients with advanced breast carcinoma

✍ P. A. J. Speth; P. C. M. Linssen; L. V. A. M. Beex; J. B. M. Boezeman; C. Haanen 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 481 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: A crossover study comparing infusion with an infusion-capsule combination

✍ R. Kirsten; K. Nelson; K. -H. Molz; R. Haerlin; V. W. Steinijans 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 453 KB

Antibody-dependent cellular cytotoxicity

Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: A prospective study

✍ Dr. Gary R. Pearson; H. Bryan Neel III; Louis H. Weiland; Susan E. Mulroney; Wil 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 603 KB

## Abstract It has previously been reported that antibody‐dependent cellular cytotoxicity (ADCC) levels determined at diagnosis against Epstein‐Barr virus (EBV)‐specific membrane antigens (MA) are predictive of disease course following therapy in patients with nasopharyngeal carcinoma (NPC). In gen

Pegylated liposomal doxorubicin and gemc

Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma : Results of a phase 2 study

✍ Giuseppe Lombardi; Fable Zustovich; Fabio Farinati; Umberto Cillo; Alessandro Vi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views